US Stock MarketDetailed Quotes
GNTA Genenta Science
- 4.631
- -0.229-4.71%
Trading Nov 8 12:35 ET
84.70MMarket Cap-8737P/E (TTM)
5.060High4.630Low16.61KVolume5.060Open4.860Pre Close80.64KTurnover0.15%Turnover RatioLossP/E (Static)18.29MShares7.28052wk High4.66P/B52.00MFloat Cap2.20052wk Low--Dividend TTM11.23MShs Float13.130Historical High--Div YieldTTM8.85%Amplitude2.200Historical Low4.855Avg Price1Lot Size
Genenta Science Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | |||||
| Cash flow from continuing operating activities | -51.05%-11.21M | -6.61%-7.42M | -15.11%-6.96M | -142.74%-6.04M | -2.49M |
| Net income from continuing operations | -37.36%-11.65M | -53.32%-8.48M | 1.12%-5.53M | -21.63%-5.59M | ---4.6M |
| Operating gains losses | -16.23%75.69K | 582.90%90.36K | 118.48%13.23K | 24.43%6.06K | --4.87K |
| Depreciation and amortization | 591.42%42.45K | 25.59%6.14K | 157.32%4.89K | --1.9K | --0 |
| Change In working capital | -273.78%-417.6K | 112.36%240.3K | -111.15%-1.94M | -168.04%-920.72K | --1.35M |
| -Change in prepaid assets | -35.96%-554.04K | 9.46%-407.49K | 0.88%-450.09K | -400.54%-454.08K | --151.09K |
| -Change in payables and accrued expense | -147.58%-405.06K | 168.33%851.32K | -358.72%-1.25M | -115.32%-271.59K | --1.77M |
| -Change in other current assets | 239.50%596.94K | -44.76%-427.91K | -47.59%-295.6K | 65.98%-200.29K | ---588.68K |
| -Change in other current liabilities | -124.71%-55.44K | 372.61%224.37K | 805.51%47.48K | -71.25%5.24K | --18.24K |
| Cash from discontinued investing activities | |||||
| Operating cash flow | -51.05%-11.21M | -6.61%-7.42M | -15.11%-6.96M | -142.74%-6.04M | ---2.49M |
| Investing cash flow | |||||
| Cash flow from continuing investing activities | -54,915.39%-14.89M | -200.48%-27.07K | 56.83%-9.01K | -20.87K | 0 |
| Net PPE purchase and sale | 49.05%-13.79K | -200.48%-27.07K | 56.83%-9.01K | ---20.87K | --0 |
| Net investment purchase and sale | ---14.88M | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | |||||
| Investing cash flow | -54,915.39%-14.89M | -200.48%-27.07K | 56.83%-9.01K | ---20.87K | --0 |
| Financing cash flow | |||||
| Cash flow from continuing financing activities | 531 | 0 | 1,968.80%28.74M | -90.59%1.39M | 14.77M |
| Net common stock issuance | --531 | --0 | 1,815.55%28.74M | -90.05%1.5M | --15.09M |
| Proceeds from stock option exercised by employees | --0 | --0 | --543 | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | 65.11%-111.12K | ---318.51K |
| Cash from discontinued financing activities | |||||
| Financing cash flow | --531 | --0 | 1,968.80%28.74M | -90.59%1.39M | --14.77M |
| Net cash flow | |||||
| Beginning cash position | -19.99%29.79M | 140.80%37.24M | -23.22%15.47M | 156.14%20.14M | --7.86M |
| Current changes in cash | -250.52%-26.1M | -134.19%-7.45M | 565.66%21.77M | -138.09%-4.68M | --12.28M |
| Effect of exchange rate changes | ---6.28K | --0 | --0 | ---- | ---- |
| End cash Position | -87.61%3.69M | -19.99%29.79M | 140.80%37.24M | -23.22%15.47M | --20.14M |
| Free cash flow | -50.68%-11.22M | -6.86%-7.45M | -14.87%-6.97M | -143.57%-6.07M | ---2.49M |
| Currency Unit | EUR | EUR | EUR | EUR | EUR |
| Audit Opinions | Unqualified Opinion | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data